1492 Capital Management LLC Mannkind Corp Transaction History

1492 Capital Management LLC

$233 Million
Q3 2025

A detailed history of 1492 Capital Management LLC transactions in Mannkind Corp stock. As of the latest transaction made, 1492 Capital Management LLC holds 504,244 shares of MNKD stock, worth $2.55 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

504,244

Previous 461,550 9.25%

Holding current value

$2.55 Million

Previous $1.73 Million 56.84%

% of portfolio

1.16%

Previous 0.87%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.42 - $5.74 $146,013 - $245,063	42,694 Added 9.25%	504,244 $2.71 Million
Q2 2025 Aug 13, 2025	SELL	$3.71 - $5.04 $58,232 - $79,107	-15,696 Reduced 3.29%	461,550 $1.73 Million
Q1 2025 May 06, 2025	SELL	$4.92 - $6.6 $31,261 - $41,936	-6,354 Reduced 1.31%	477,246 $2.4 Million
Q4 2024 Feb 13, 2025	SELL	$5.93 - $7.44 $66,564 - $83,514	-11,225 Reduced 2.27%	483,600 $3.11 Million
Q3 2024 Nov 13, 2024	SELL	$5.01 - $6.7 $73,611 - $98,443	-14,693 Reduced 2.88%	494,825 $3.11 Million

Q2 2024 Aug 13, 2024	SELL	$4.05 - $5.43 $15,697 - $21,046	-3,876 Reduced 0.75%	509,518 $2.66 Million
Q1 2024 May 13, 2024	SELL	$3.25 - $5.27 $11,550 - $18,729	-3,554 Reduced 0.69%	513,394 $2.33 Million
Q4 2023 Feb 12, 2024	SELL	$3.34 - $4.29 $13,694 - $17,589	-4,100 Reduced 0.79%	516,948 $1.88 Million
Q3 2023 Nov 13, 2023	SELL	$3.91 - $5.45 $58,724 - $81,853	-15,019 Reduced 2.8%	521,048 $2.15 Million
Q2 2023 Aug 11, 2023	SELL	$3.72 - $4.79 $2,447 - $3,151	-658 Reduced 0.12%	536,067 $2.18 Million
Q1 2023 May 12, 2023	SELL	$3.95 - $5.63 $4,364 - $6,221	-1,105 Reduced 0.21%	536,725 $2.2 Million
Q4 2022 Feb 13, 2023	SELL	$3.02 - $5.37 $26,817 - $47,685	-8,880 Reduced 1.62%	537,830 $2.83 Million
Q3 2022 Nov 10, 2022	BUY	$2.99 - $4.35 $27,460 - $39,950	9,184 Added 1.71%	546,710 $1.69 Million
Q2 2022 Aug 10, 2022	SELL	$2.67 - $4.77 $52,131 - $93,134	-19,525 Reduced 3.51%	537,526 $2.05 Million
Q1 2022 May 12, 2022	BUY	$2.62 - $4.45 $60,844 - $103,342	23,223 Added 4.35%	557,051 $2.05 Million
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $13,089 - $17,355	3,232 Added 0.61%	533,828 $2.33 Million
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $38,227 - $53,851	9,827 Added 1.89%	530,596 $2.31 Million
Q2 2021 Aug 13, 2021	BUY	$3.61 - $5.45 $278,056 - $419,780	77,024 Added 17.36%	520,769 $2.84 Million
Q1 2021 May 12, 2021	BUY	$3.14 - $6.14 $1.25 Million - $2.43 Million	396,537 Added 839.98%	443,745 $1.74 Million
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $21,981 - $49,611	12,280 Added 35.16%	47,208 $148,000
Q3 2020 Nov 13, 2020	BUY	$1.56 - $2.08 $54,487 - $72,650	34,928 New	34,928 $66,000

Others Institutions Holding MNKD

# of Institutions

259

Shares Held

165M

Call Options Held

2.76M

Put Options Held

689K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.3B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.

Account

1492 Capital Management LLC Mannkind Corp Transaction History